|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent NERV insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why NERV insider buys are important for investors to follow.
Date | Insider | Price | Amount |
9-10-2020 Insider Buy |
G. Jan Van Heek Director |
$2.97
CAGR »
|
$20,790.00 7,000 shares |
6-27-2019 Insider Buy |
William F. Doyle Director |
$5.50
CAGR »
|
$19,250.00 3,500 shares |
6-26-2019 Insider Buy |
David Kupfer Director |
$5.55
CAGR »
|
$55,500.00 10,000 shares |
6-26-2019 Insider Buy |
Hans Peter Hasler Director |
$5.60
CAGR »
|
$56,000.00 10,000 shares |
6-26-2019 Insider Buy |
Jeryl L. Hilleman Director |
$5.25
CAGR »
|
$5,250.00 1,000 shares |
6-26-2019 Insider Buy |
G. Jan Van Heek Director |
$5.37
CAGR »
|
$53,700.00 10,000 shares |
12-20-2018 Insider Buy |
William F. Doyle Director |
$6.50
CAGR »
|
$13,000.00 2,000 shares |
11-20-2018 Insider Buy |
William F. Doyle Director |
$8.20
CAGR »
|
$16,400.00 2,000 shares |
10-11-2018 Insider Buy |
William F. Doyle Director |
$10.00
CAGR »
|
$6,000.00 600 shares |
9-14-2018 Insider Buy |
William F. Doyle Director |
$10.50
CAGR »
|
$23,100.00 2,200 shares |
9-11-2018 Insider Buy |
William F. Doyle Director |
$9.80
CAGR »
|
$78,506.92 8,011 shares |
3-20-2017 Insider Buy |
Marc D. Beer Director |
$8.12
CAGR »
|
$405,750.00 50,000 shares |
6-21-2016 Insider Buy |
David Kupfer Director |
$10.84
CAGR »
|
$603,000.97 55,635 shares |
3-17-2016 Insider Buy |
David Kupfer Director |
$5.51
CAGR »
|
$999,998.88 181,488 shares |
3-18-2015 Insider Buy |
Francesco De Rubertis Director and >10% Owner |
$4.81
CAGR »
|
$974,669.54 202,634 shares |
3-18-2015 Insider Buy |
Michele Ollier Director and >10% Owner |
$4.81
CAGR »
|
$974,669.54 202,634 shares |
3-18-2015 Insider Buy |
Venture Associates Ltd Index III >10% Owner |
$4.81
CAGR »
|
$974,669.54 202,634 shares |
3-13-2015 Insider Buy |
& Johnson Johnson >10% Owner |
$4.81
CAGR »
|
$2,924,013.43 607,903 shares |
7-1-2014 Insider Buy |
Coelho Rogerio Vivaldi President and CEO |
$6.00
CAGR »
|
$250,002.00 41,667 shares |
7-7-2014 Insider Buy |
Care Capital III LLC >10% Owner |
$6.00
CAGR »
|
$4,425,000.00 737,500 shares |
7-7-2014 Insider Buy |
Lorenzo Pellegrini Director and >10% Owner |
$6.00
CAGR »
|
$4,425,000.00 737,500 shares |
7-1-2014 Insider Buy |
G. Jan Van Heek Director |
$6.00
CAGR »
|
$19,998.00 3,333 shares |
7-1-2014 Insider Buy |
Joseph H. Reilly Chief Business Officer |
$6.00
CAGR »
|
$49,998.00 8,333 shares |
7-7-2014 Insider Buy |
Michele Ollier Director and >10% Owner |
$6.00
CAGR »
|
$9,724,998.00 1,620,833 shares |
7-7-2014 Insider Buy |
Venture Associates Ltd Index III >10% Owner |
$6.00
CAGR »
|
$9,724,998.00 1,620,833 shares |
7-7-2014 Insider Buy |
Francesco De Rubertis Director and >10% Owner |
$6.00
CAGR »
|
$9,724,998.00 1,620,833 shares |
7-1-2014 Insider Buy |
Frederick W. Ahlholm Chief Accounting Officer |
$6.00
CAGR »
|
$60,000.00 10,000 shares |
7-1-2014 Insider Buy |
Geoff Race EVP and CFO |
$6.00
CAGR »
|
$199,998.00 33,333 shares |
Also See: Institutional Holders of NERV
Also See: SEC filings
Below we present the annualized performance delivered by NERV stock since 9-10-2020 (the date of the most recent
insider purchase). The performance of the investment from the time NERV insider buying occurred is the ultimate
test of whether insiders were right about NERV being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/11/2020 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$22.96 |
|
End price/share: |
$2.50 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-89.11% |
|
Average Annual Total Return: |
-45.96% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,089.04 |
|
Years: |
3.60 |
|
NERV Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent NERV insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding NERV
|
|